Bristol Myers Squibb is deploying a second NVIDIA DGX SuperPOD as part of an effort to expand its artificial intelligence capabilities in life sciences, according to an NVIDIA Newsroom announcement. The new system is being built on NVIDIA’s Vera Rubin platform. BMS already operates one of the largest AI computing clusters in the life sciences sector and has cited results from its existing infrastructure. The pharmaceutical company’s latest deployment is aimed at supporting further AI-driven work across its operations. NVIDIA described the project as one of the most advanced AI factories in the life sciences industry. Post navigation Louvre Masterpieces Arrive on Samsung TVs NVIDIA Adds Omniverse Tools for AI Agents